A hormone signal, rather than the hormone.
Sermorelin is a lab-made version of part of growth hormone-releasing hormone. That natural hormone signals the pituitary, a small gland beneath the brain, to release growth hormone. Sermorelin and growth hormone are different substances.
A signal to a gland describes a biological action. It does not establish a benefit for training, sleep, energy or aging. The body part being measured and the people in a study both matter when reading a claim.
The past approval had specific uses.
Sermorelin once had FDA-approved products for testing growth hormone release and for certain children with growth hormone deficiency. A deficiency means the body does not make enough of a hormone. Those approvals were not for adult wellness.
The FDA withdrew the product approvals in 2009 after the manufacturer requested it. The agency later found that withdrawal was not for safety or effectiveness reasons. That finding does not approve a medicine sold today. There is no current FDA-approved sermorelin product.
Old studies need their context.
Much of the older clinical research involved children with a diagnosed hormone problem. A change measured in that group cannot become a promise about a healthy adult’s recovery or sleep. A blood test result is also a different outcome from a change someone can feel in daily life.
Older studies described flushing and discomfort where an injection was given. They do not provide a complete safety record for adult use or for current compounded preparations. Those preparations are not FDA-approved. A provider’s review needs to account for that uncertainty.
Today’s question is about today’s preparation.
Promise offers sermorelin consultations. Compounded sermorelin is not FDA-approved. Past approval does not carry over to a compounded product. A prescription is separate from a pharmacy’s decision about whether it can lawfully prepare it.
- Which findings concern adults with a condition like mine?
- What would a hormone test tell us, and what would it leave unanswered?
- What monitoring and follow-up would be part of care?
The recovery and peptides guide puts training questions in context. For the distinction between a licensed review and FDA approval, start with the common questions.